Nuclear DNA-polymerase estimation in human leukaemic myeloblasts

Area of Science:

• Molecular Biology
• Hematology
• Cancer Research

Background:

• Assessing DNA-polymerase activity in leukaemic myeloblasts is crucial for understanding leukemia.
• The incorporation of 3H-thymidine-5-triphosphate (3H-TTP) is a method to detect DNA-polymerase presence.
• This technique estimates the proportion of cells containing active DNA-polymerase and primer-template DNA.

Purpose of the Study:

• To evaluate the DNA-polymerase activity in leukaemic myeloblasts using 3H-TTP incorporation.
• To investigate the effect of cytosine arabinoside and methotrexate on DNA-polymerase activity in acute myeloid leukemia.

Main Methods:

• Utilized a technique measuring 3H-thymidine-5-triphosphate (3H-TTP) incorporation to detect DNA-polymerase.
• Assessed the 3H-TTP labelling index (3H-TTP LI) in leukaemic myeloblasts from six acute myeloid leukemia patients.
• Administered single doses of cytosine arabinoside and methotrexate to observe changes in 3H-TTP LI and DNA synthesis.

Main Results:

• The 3H-TTP LI was significantly higher than the fraction of cells in DNA synthesis in untreated acute myeloid leukemia.
• Cytosine arabinoside administration caused a marked decrease in 3H-TTP LI, indicating direct DNA-polymerase inhibition.
• Methotrexate treatment also led to a reduction in 3H-TTP LI, while 3H-thymidine labeling remained unchanged.

Conclusions:

• Leukaemic myeloblasts exhibit substantial DNA-polymerase activity, exceeding their DNA synthesis rate.
• Cytosine arabinoside directly inhibits DNA-polymerase, offering a potential therapeutic mechanism in leukemia.
• The findings highlight the utility of 3H-TTP LI as a marker for DNA-polymerase activity and drug effects in leukemia.